Hao‐Wen Sim

Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA)

J. Randolph Hecht, Sara Lonardi, Johanna C. Bendell et al. · Journal of Clinical Oncology · 2021 · 102 citations · Full text

A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated<i>MGMT</i>glioblastoma: the VERTU study

Hao‐Wen Sim, Kerrie L. McDonald, Zarnie Lwin et al. · Neuro-Oncology · 2021 · 81 citations · Full text

First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

José Manuel Ruiz-Morales, Marcin Świerkowski, J. Connor Wells et al. · European Journal of Cancer · 2016 · 70 citations

Urology, Genitourinary Cancer, Medicine +3

Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Steven Yip, J. Connor Wells, Raphael Brandão Moreira et al. · Cancer · 2018 · 66 citations · Full text

Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome—Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Frede Donskov, Wanling Xie, A. J. Overby et al. · European Urology Oncology · 2020 · 56 citations · Full text